ShockWave Medical (SWAV)
(Real Time Quote from BATS)
$330.12 USD
+0.61 (0.19%)
Updated Apr 30, 2024 03:00 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for ShockWave Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 147.28 | 216.00 | -9.14 | -65.70 | -51.11 |
Depreciation/Amortization & Depletion | 11.87 | 5.39 | 6.05 | 3.99 | 2.72 |
Net Change from Assets/Liabilities | -43.86 | -57.93 | -16.52 | -20.31 | -3.49 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 80.77 | -45.72 | 34.64 | 10.84 | 3.78 |
Net Cash From Operating Activities | 196.05 | 117.73 | 15.04 | -71.18 | -48.11 |
Property & Equipment | -30.60 | -25.13 | -12.44 | -11.52 | -3.82 |
Acquisition/ Disposition of Subsidiaries | -94.41 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -500.72 | -37.02 | 38.86 | -95.95 | -55.73 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -625.73 | -62.15 | 26.42 | -107.47 | -59.54 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 738.06 | 7.05 | 5.89 | 89.48 | 209.61 |
Issuance (Repayment) of Debt | -105.00 | 5.97 | 0.00 | 2.15 | -1.67 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -32.66 | -0.02 | -8.34 | -1.60 | 0.11 |
Net Cash from Financing Activities | 600.40 | 13.00 | -2.45 | 90.04 | 208.05 |
Effect of Exchange Rate Changes | 0.80 | -1.15 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 171.52 | 67.43 | 39.00 | -88.62 | 100.40 |
Cash at Beginning of Period | 158.30 | 90.87 | 51.87 | 140.50 | 40.09 |
Cash at End of Period | 329.83 | 158.30 | 90.87 | 51.87 | 140.50 |
Diluted Net EPS | 3.85 | 5.70 | -0.26 | -1.99 | -2.14 |
Fiscal Year End for ShockWave Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 147.28 | 102.97 | 67.99 | 39.13 |
Depreciation/Amortization & Depletion | NA | 11.87 | 7.85 | 4.34 | 1.74 |
Net Change from Assets/Liabilities | NA | -43.86 | -49.08 | -34.02 | -22.50 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 80.77 | 62.61 | 35.39 | 15.60 |
Net Cash From Operating Activities | NA | 196.05 | 124.35 | 73.70 | 33.96 |
Property & Equipment | NA | -30.60 | -22.47 | -15.94 | -7.19 |
Acquisition/ Disposition of Subsidiaries | NA | -94.41 | -94.41 | -94.41 | 0.00 |
Investments | NA | -500.72 | -266.58 | 32.76 | 13.37 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -625.73 | -383.47 | -77.59 | 6.18 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 738.06 | 7.41 | 3.82 | 3.41 |
Issuance (Repayment) of Debt | NA | -105.00 | 625.81 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -32.66 | -32.66 | -16.24 | 80.00 |
Net Cash from Financing Activities | NA | 600.40 | 600.57 | -12.43 | 83.41 |
Effect of Exchange Rate Changes | NA | 0.80 | -0.30 | 0.47 | 0.79 |
Net Change In Cash & Equivalents | NA | 171.52 | 341.15 | -15.85 | 124.35 |
Cash at Beginning of Period | NA | 158.30 | 158.30 | 158.30 | 158.30 |
Cash at End of Period | NA | 329.83 | 499.45 | 142.45 | 282.65 |
Diluted Net EPS | NA | 1.14 | 0.92 | 0.76 | 1.03 |